Cell signaling properties of inositol hexaphosphate (IP6)

Nutrigenomics

Volumn , Issue , 2005, Pages 397-420

  Shamsuddin, Abulkalam M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750859284     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (90)

1. Harland BF, Oberleas D. Phytate in foods. World Rev Nutr Diet 1987; 52:235-259.
2. Lott JNA. Accumulation of seed reserves of phosphorous and other minerals. In: Murray DR, ed. Seed Physiology. New York: Academic Press, 1984:139-166.
3. Reddy NR, Sathe SK, Salunke DK. Phytates in legumes and cereals. Adv Food Res 1982; 28:1-89.
4. Cosgrove DJ. Inositolhexakisphosphates. In: Cosgrove DJ, ed. Inositol Phosphates. Their Chemistry, Biochemistry and Physiology. Netherlands: Elsevier Scientific Publishing Company, 1980:26-43.
5. Sasakawa N, Sharif M, Hanley MR. Metabolism and biological activities of inositol pentakisphosphates and inositol hexakisphosphate. Biochem Pharmacology 1995; 50:137-146.
6. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341:197-205.
7. 3H]aspartate release in cultured cerebellar neurons. J Neurochem 1990; 53:1026-1030.
8. 2+ influx in cultured anterior pituitary cells. J Endocrinol Invest 1989; 12:23.
9. 2+ and prolactin secretion from perifused pituitary cells. J Gen Physiolo 1988; 92:P8A-P9A.
10. Copani A, Bruno V, Cavallaro S, Fiore L, Sortino MA, Canonico PL, Nicoletti F. Receptors for inositolhexakisphosphate in neurons and anterior pituitary cells. Pharmacol Rese 1990; 22(suppl 1):83-84.
11. Nicoletti F, Bruno V, Cavallaro S, Caponi A, Sortino MA, Canonico PL. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary. Mol Pharmacol 1990; 37:689-693.
12. Theibert AB, Estevez VA, Ferris CD, Danoff SK, Barrow RK, Prestwich AD, Snyder SH. Inositol 1,3,4,5-tetrakisphosphate and inositol hexakisphosphate receptor proteins: isolation and characterization from rat brain. Proc Natl Acad Sci USA 1991; 88:3165-3169.
13. Huisaman B, Lochner A. Inositol polyphosphates and their binding proteins—a short review. Mol Cell Biochem 1996; 157:229-232.
14. 3H]inositol hexakisphosphate binding to rat cerebellar membranes. J Biol Chem 1993; 268:1032-1038.
15. Vallejo M, Jackson TR, Lightman S, Hanley MR. Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature 1987; 330:656-658.
16. Hanley MR, Jackson TR, Vallejo M, Patterson SI, Thastrup O, Lightman S, Rogers J, Henderson G, Pini A. Neural function: metabolism and actions of inositol metabolites in mammalian brain. Philos Trans R Soc Lond Biol Sci 1988; 320:381-398.
17. Rowley KG, Gundlach AL, Cincotta M, Louis WJ. Inositol hexakisphosphate binding sites in rat heart and brain. Br J Pharmacol 1996; 118:1615-1620.
18. 2+ efflux from inside-out plasma membrane vesicles containing 104 kDa GAP1IP4protein BP. Biochem J 1996; 315:1027-1034.
19. Kitchen E, Condliffe AM, Rossi AG, Haslett C, Chilvers ER. Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors. Br J Pharmacol 1996; 117:979-985.
20. 6) on the stimulated respiratory burst in human neutrophils. Biochim Biophys Acta 1991; 1094:309-316.
21. 6 on human neutrophil cytokine production and cell morphology. Anticancer Res 1999; 19:3711-3715.
22. Samanta S, Dalal B, Biswas S, Biswas BB. Myoinositol tris-phosphate-phytase complex as an elicitor in calcium mobilization in plants. Biochem Biophys Res Commun 1993; 191:427-434.
23. 2+ mobilization in plants. Biochemistry 1996; 35:4994-5001.
24. Lemtiri-Chlieh F, MacRobbie EA, Webb AA, Manison NF, Brownlee C, Skepper JN, Chen J, Prestwich GD, Brearley CA. Inositol hexakisphosphate mobilizes an endo-membrane store of calcium in guard cells. Proc Natl Acad Sci USA 2003; 100: 10091-10095.
25. Cole KE, Smith M, Xu J-F, Vucenik I, Shamsuddin AM. Modulation of the intracellular calcium signal in human colon cancer cells by the novel antineoplastic agent inositol hexaphosphate. Anticancer Res 1997; 17:4070-4071.
26. Fukuda M, Mikoshiba K. The function of inositol high phosphate binding proteins. Bioessays 1997; 19:593-603.
27. Ji H, Sandberg K, Baukal AJ, Catt KJ. Metabolism of inositol pentakisphosphate to inositol hexakisphosphate in Xenopus laevis oocytes. J Biol Chem 1989; 264: 20185-20188.
28. Guse AH, Greiner E, Emmrich F, Brand K. Mass changes of inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate during cell cycle progression in rat thymocytes. J Biol Chem 1993; 268:7129-7133.
29. 2+ channel activity by inositol hexakisphosphate. Science 1997; 278:471-474.
30. 2+-mediated exocytosis of insulin by activation of protein kinase C. Proc Natl Acad Sci USA 1997; 94:4435-4439.
31. Ferry S, Matsuda M, Yoshida H, Hirata M. Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NF^B-mediated cell survival pathway. Carcinogenesis 2002; 23:2031-2041.
32. Singh RP, Agarwal C, Agarwal R. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 2003; 24:555-563.
33. Lu YJ, He Y, Sui SF. Inositol hexakisphosphate (InsP6) can weaken the Ca(2+)-dependent membrane binding of C2AB domain of synaptotagmin I. FEBS Lett 2002; 527:22-26.
34. Hoy M, Efanov AM, Bertorello AM, Zaitsev SV, Olsen HL, Bokvist K, Leibiger B, Leibiger IB, J Zwiller J, Berggren P-O, Gromada J. Inositol hexakisphosphate promotes dynamin I-mediated endocytosis. Proc Natl Acad Sci USA 2002; 99:6773-6777.
35. Lamaze C, Baba T, Redelmeier TE, Schmid SL. Recruitment of epidermal growth factor and transferrin receptors into coated pits in vitro: differing biochemical requirements. Mol Biol Cell 1993; 4:715-727.
36. Zi X, Singh RP, Agarwal R. Impairment of erbB1 receptor and fluid phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 2000; 21:2225-2235.
37. Voglmaier SM, Keen JH, Murphy JE, Ferris CD, Prestwich GD, Snyder SH, Theibert AB. Inositol hexakisphosphate receptor identified as the clathrin assembly protein AP-2. Biochem Biophys Res Commun 1992; 187:158-163.
38. 6): an antagonist of fibroblast growth factor receptor binding and activity. In Vitro Cell Dev Biol Anim 1994; 30A:783-789.
39. 6) and insulin-like growth factor II receptor binding sites in the rat brain. Neuroreport 1994; 5:625-628.
40. Couchman JR, Vogt S, Lim ST, Lim Y, Oh ES, Prestwich GD, Theibert A, Lee W, Woods A. Regulation of inositol phospholipid binding and signaling through syndecan-4. J Biol Chem 2002; 277:49296-49303.
41. 6) inhibits key events of cancer metastases: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells. Anticancer Res 2003; 23.
42. 6) inhibits key events of cancer metastases: II. Effects on integrins and focal adhesions. Anticancer Res 2003; 23:3681-3690.
43. 6) and inositol: from laboratory to clinic. J Nutrition 2003; 133:3778S-3784S.
44. Shamsuddin AM. Anti-cancer function of phytic acid. Int J Food Sci Technol 2002; 37:769-782.
45. 6: a novel anti-cancer agent. Life Sci 1997; 61:343-354.
46. Shamsuddin AM, Ullah A, Chakravarthy A. Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 1989; 10:1461-1463.
47. 6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res 1995; 15:2479-2488.
48. 6). Anticancer Res 2001; 21:2393-2404.
49. 6 dephosphorylation in WRK-1 rat mammary epithelial cells and exhibit transient concentration changes during the cell cycle. Biochem Soc Trans 1995; 23:169S.
50. 6) on human normal and leukaemic hematopoietic cells. Brit J Haematology 2002; 117:577-587.
51. 6) in breast cancer cells is mediated by increase in p27 and decrease in Rb protein phosphorylation. Proc Amer Assoc Cancer Res 2000; 41:339.
52. 2+-mediated exocytosis of insulin by activation of protein kinase C. Proc Natl Acad Sci USA 1997; 94:4435-4439.
53. Hoy M, Berggren PO, Gromada J. Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells. J Biol Chem 2003; 278:35168-35171.
54. Nickel KP, Belury MA. Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes. Cancer Lett 1999; 140:105-111.
55. Shamsuddin AM, Baten A, Lalwani ND. Effect of inositol hexaphosphate on growth and differentiation in K562 erythroleukemia cell line. Cancer Lett 1992; 64:195-202.
56. Sakamoto K, Venkatraman G, Shamsuddin AM. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 1993; 14:1815-1819.
57. Shamsuddin AM, Yang G-Y. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 1995; 16:1975-1979.
58. 6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res 1996; 16:3287-3292.
59. 6): inhibition oh human rhabdomyosarcoma in vitro and in vivo. Anticancer Res 1998; 18:1377-1384.
60. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res 1999; 59:542-546.
61. Pittet D, Schlegel W, Lew DP, Monod A, Mayr GW. Mass changes in inositol tetrakis-and pentakisphosphate isomers induced by chemotactic peptide stimulation in HL-60 cells. J Biol Chem 1989; 264:18489-18493.
62. Huang C, Ma W-Y, Hecht SS, Dong Z. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase. Cancer Res 1997; 57:2873-2878.
63. Cocco L, Martelli A, Barnabe O, Manzoli FA. Nuclear inositol lipid signaling. Advan Enzyme Regul 2001; 41:361-384.
64. Cocco L, Gilmour RS, Ognibene A, Manzoni FA, Irvine RF. Synthesis of polyphosphoinositides in nuclei of friend cells. Evidence of phosphoinositide metabolism inside the nucleus which changes with cell differentiation. Biochem J 1987; 248:765-770.
65. York JD, Odom AR, Murphy R, Ives EB, Wente SR. A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 1999; 285:96-100.
66. 3 and osmotic regulation. Biochem J 1998; 335:671-679.
67. Odom AR, Stahlberg A, Wente SR, York JD. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science 2000; 287:2026-2029.
68. Shen X, Xiao H, Ranallo R, Wu W-H, Wu C. Modulation of ATP-dependent chromatin remodeling complexes by inositol polyphosphates. Science 2003; 299:112-114.
69. Steger DJ, Haswell ES, Miller AL, Wente SR, O’Shea EK. Regulation of chromatic remodeling by inositol polyphosphates. Science 2003; 299:114-116.
70. Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R. Inositol hexaphosphate inhibits constitutive activation of NF-kB in androgen-independent human prostate carcinoma DU145 Cells. Anticancer Research 2003; 23:3855-3861.
71. Chen N, Ma WY, Dong Z. Inositol hexaphosphate inhibits ultraviolet B-induced signal transduction. Mol Carcinog 2001; 31:139-144.
72. Thompson LU, Zhang L. Phytic acid and minerals: effect of early markers of risk for mammary and colon carcinogenesis. Carcinogenesis 1991; 12:2041-2045.
73. Hanakahi LA, Bartlet-Jones M, Chappell C, Pappin D, West SC. Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 2000; 102: 721-729.
74. cs. J Biol Chem 2002; 277:10756-10759.
75. Chen N, Ma W-Y, Dong Z. Inositol hexaphosphate inhibits ultraviolet B-induced signal transduction. Mol Carcinog 2001; 31:139-144.
76. 6) differentially modulates the expression of PKC in MCF-7 and MDA-MB 231 cells. Proc Am Assoc Cancer Res 1999; 40:653.
77. Morton RK, Raison JK. A complete intracellular unit for incorporation of amino-acid into storage protein utilizing adenosine triphosphate generated from phytate. Nature 1963; 200:429-433.
78. Biswas S, Maity IB, Chakrabarti S, Biswas BB. Purification and characterization of myo-inositol hexaphosphate-adenosine diphosphate phosphotransferase from Phaseolus aureus. Arch Biochem Biophys 1978; 185:557-566.
79. Phillippy BQ, Ullah AH, Ehrlich KC. Purification and some properties of inositol 1,3,4,5,6-pentakisphosphate 2-kinase from immature soybean seeds. J Biol Chem 1994; 269:28393-28399.
80. Elsayed A, Chakravarthy A, Shamsuddin A. Inositol hexaphosphate from corn decreased the frequency of colorectal cancer in azoxymethane-treated rats. Seventy-sixth Annual Meeting of the U.S.-Canadian Division of the International Academy of Pathology, Chicago, IL, Mar 9-13, 1987. Lab Investig 1987; 56:21A.
81. 6) inhibits large intestinal carcinogenesis in F-344 rats. Seventy-first Annual Meeting of the Federation of American Societies for Experimental Biology, Washington, DC, Mar 29-Apr 3, 1987. Fed Proc 1987; 46:585.
82. Shamsuddin AM, Elsayed AM, Ullah A. Suppression of large intestinal cancer in F-344 rats by inositol hexaphosphate. Carcinogenesis 1988; 9:577-580.
83. Sun AS, Yes HC, Wang LH, Huang YP, Maeda H, Pivazyan A, Hsu C, Bruckner HW, Fasy TM. Pilot study of a specific dietary supplement in tumor bearing mice and stage IIIB and IV non-small cell lung cancer patients. Nutr Cancer 2001; 39:85-95.
84. Druzijanic N, Juricic J, Perko Z, Kraljevic D. IP-6 & inositol: adjuvant to chemotherapy of colon cancer. A pilot clinical trial. European Association of Cancer Research Annual Meeting EACR 17, Granada, Spain, Jun 8-11, 2002. Rev Oncología 2002; 4(suppl 1):171.
85. Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauza A, Garcia-Raja A, Conte A. Urinary phytate in calcium oxalate stone-formers and healthy people. Dietary effects on phytate excretion. Scand J Urol Nephrol 2000; 34:162-164.
86. Jariwalla RJ, Sabin R, Lawson S, Herman ZS. Lowering of serum cholesterol and triglycerides and modulations by dietary phytate. J Appl Nutr 1990; 42:18-28.
87. 6). Anticancer Res 1999; 19:3689-3693.
88. Rao PS, Liu XK, Das DK, Weinstein GS, Tyras DH. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant. Ann Thorac Surgery 1991; 52:908-912.
89. 3) in malignant cells, tissues and biological fluids. Life Sci 2002; 71:1535-1546.
90. 6 or phytate) in humans. Biofactors 2001; 15:53-61.